Results for the year ended 31 December 2016
READING, UNITED KINGDOM - ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, will announce its results for the full year ended 31 December 2016 on Thursday 2 March 2017, at 7.00am GMT / 2.00am EST.
There will be an analysts and investors meeting later that day at 9.00am GMT / 4.00am EST, which will be available to view live through the ConvaTec website at https://www.convatecgroup.com/investors/. A recording will be available on the site shortly afterwards.
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com
Enquiries
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Rebecca Fitchett, Finsbury +44 (0)207 251 3801